Albumin & Creatinine Tests Market - Regional Analysis
North American Market Insights
North America industry is set to account for largest revenue share by 2035. Growth in the regional market can be attributed primarily to the increasing prevalence of chronic diseases and the rise in healthcare spending by the general population. Furthermore, chronic diseases such as type 1 or type 2 diabetes, high blood pressure, and obesity can lead to kidney diseases. With the growing incidence of these diseases, rapid urine testing has become an increasingly crucial method of diagnosing kidney disorders. The prevalence of obesity, a chronic disease condition, in the U.S. from 2017 to 2020 rose from 30.5% to 41.9% and in the same period, the prevalence of severe obesity rose from 4.7% to 9.2%, as per the Centers for Disease Control and Prevention. Additionally, according to the same source, more than 37 million Americans suffer from diabetes, with approximately 90-95% having diabetes type 2 most commonly occurs in adults over 45.
